Short Interest in Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) Decreases By 16.2%

Genomma Lab Internacional, S.A.B. de C.V. (OTCMKTS:GNMLF) saw a significant decline in short interest in February. As of February 28th, there was short interest totalling 2,282,900 shares, a decline of 16.2% from the February 13th total of 2,723,600 shares. Based on an average trading volume of 100 shares, the short-interest ratio is currently 22,829.0 days.

Genomma Lab Internacional Price Performance

Genomma Lab Internacional stock remained flat at $1.43 during mid-day trading on Tuesday. The firm’s fifty day moving average is $1.36 and its 200 day moving average is $1.24. Genomma Lab Internacional has a one year low of $0.79 and a one year high of $1.43.

Genomma Lab Internacional Company Profile

Genomma Lab Internacional, SAB. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition.